Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravaginal isosorbide dinitrate for uterine artery high-resistance patients undergoing first frozen embryo transfer
ChiCTR1900023968Phase 4Not yet recruiting
- Sponsor
- Ruijin Hospital
- Start
- Jul 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of isosorbide dinitrate and aspirin in None (2 arms), sponsored by Ruijin Hospital. Primary endpoint: Clinical pregnancy rate. Planned start Jul 2019; status: not yet recruiting.
02
Drugs
isosorbide dinitrateaspirin
Beyond the preview
Go deeper on ChiCTR1900023968.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900023968.